about
n-3 Fatty acid supplementation and proresolving mediators of inflammationAssociation between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver diseaseRescue of glucocorticoid-programmed adipocyte inflammation by omega-3 fatty acid supplementation in the rat.Cerebrospinal fluid levels of inflammation, oxidative stress and NAD+ are linked to differences in plasma carotenoid concentrations.Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597)Overfeeding reduces insulin sensitivity and increases oxidative stress, without altering markers of mitochondrial content and function in humans.Supplementation with N-3 long-chain polyunsaturated fatty acids or olive oil in men and women with renal disease induces differential changes in the DNA methylation of FADS2 and ELOVL5 in peripheral blood mononuclear cellsEffects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors.Association of genetic Loci with glucose levels in childhood and adolescence: a meta-analysis of over 6,000 children.Are isofurans and neuroprostanes increased after subarachnoid hemorrhage and traumatic brain injury?Comparing the effects of sun exposure and vitamin D supplementation on vitamin D insufficiency, and immune and cardio-metabolic function: the Sun Exposure and Vitamin D Supplementation (SEDS) Study.Is there a role for isofurans and neuroprostanes in pre-eclampsia and normal pregnancy?The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modificationsLoci affecting gamma-glutamyl transferase in adults and adolescents show age × SNP interaction and cardiometabolic disease associations.Clinical cardiovascular risk during young adulthood in offspring of hypertensive pregnancies: insights from a 20-year prospective follow-up birth cohortIdentification of a dietary pattern associated with greater cardiometabolic risk in adolescence.Dual Energy X-Ray Absorptiometry Compared with Anthropometry in Relation to Cardio-Metabolic Risk Factors in a Young Adult Population: Is the 'Gold Standard' Tarnished?Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation.Neglecting legumes has compromised human health and sustainable food production.Regular Fat and Reduced Fat Dairy Products Show Similar Associations with Markers of Adolescent Cardiometabolic HealthChanges in dairy food and nutrient intakes in Australian adolescentsn-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney DiseaseMaternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placentaTargeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trialChanges in oxidative damage, inflammation and [NAD(H)] with age in cerebrospinal fluid.Sex differences in the association of phospholipids with components of the metabolic syndrome in young adults.Early life programming of cardiometabolic disease in the Western Australian pregnancy cohort (Raine) study.Isoprostanes and neuroprostanes: total synthesis, biological activity and biomarkers of oxidative stress in humans.Dietary n-3 PUFA and CVD: a review of the evidence.Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors.Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial.Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction.Early Life Factors, Obesity Risk, and the Metabolome of Young Adults.Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents.Relationships between depression and anxiety symptoms scores and blood pressure in young adults.F2-Isoprostanes in HDL are bound to neutral lipids and phospholipids.Gender difference in the relationship between passive smoking exposure and HDL-cholesterol levels in late adolescence.Hypothalamic-pituitary-adrenal axis activity under resting conditions and cardiovascular risk factors in adolescents.Serum 25-hydroxyvitamin D concentrations and cardiometabolic risk factors in adolescents and young adults.Preeclampsia and cardiovascular disease share genetic risk factors on chromosome 2q22.
P50
Q28270841-0A122E4A-DA6B-4584-9909-45987ED2F532Q28943559-27244DCE-C95C-4431-9A4D-86EDFADB1A73Q33617646-04777D59-9191-4F6E-8513-8B6C4BC87018Q33895668-9DCCF195-6458-4FB0-A9AE-072B3AB0DE4CQ34182691-CDBFA033-54A4-42C1-A89D-E36F2B848F23Q34269093-C2A506EB-FC57-40EC-B4B7-9205EF7257EAQ34361751-A4E1AFDE-ADB3-49AB-9580-0B1F8E4DADFEQ34453746-9E40DE16-420E-473C-8ED9-98D7777994BFQ35043398-D3154E82-AE5E-4A46-87EB-EC51A9AFD88AQ35245311-136F8084-4EBE-40AD-A09B-D03D42101310Q35339508-6680B529-E74C-4DD7-9560-F0F814B71572Q35650246-F0ED6B9A-2781-4A06-83FF-6EDB26BFA0D7Q35676161-203AFBE4-1012-4D58-94E9-2F94E45983F1Q35747157-B2AD5770-013A-46E5-8A2B-55EF8F7AC87BQ35778856-C1A31DB6-331B-4B9C-AADC-8D16C2BC4036Q35876396-AD6AFE72-EB80-4283-8D2C-C8220803557DQ36131180-855CF176-D75D-4404-8632-96CD425E3A97Q36196850-99BA7393-50B4-44B5-BF68-BF76263A33E5Q36285987-1F122F1D-EFC7-48BF-A3FE-CB7ED5F0270BQ36507445-35A301AE-AEAA-46DE-98AD-FC64ED3E1BABQ36538099-7448D205-7D76-470F-9A7F-E9AEACA900C1Q36732191-600A0E9C-FB8E-46A9-9297-1C6797D29D98Q37002704-D5E3F228-5B98-4C07-8493-F96ED69B0C2AQ37363551-4DF72C9E-C3CE-4B31-B6F5-992CFFA97065Q37478791-3CA65065-1C74-4CAB-A4F1-00ADC39C0FFAQ37726891-AD06BF35-8679-4386-AB87-7552DAC8AED5Q38025751-8D45FBC7-8150-4BC9-B1AC-37187B0DABAEQ38104205-C22868D2-9FE7-4438-9331-9BE9B41E8AA4Q38151997-BC950E39-78EA-4285-924A-4ABC8424929FQ38233967-86377462-FEA3-4D95-8E83-B735E08D5968Q38382811-DC9F06A5-F527-48A6-8BB3-081752EE9447Q38473325-E7234CEC-B553-4082-8500-737C6ECDDAD8Q38652368-BFD1D99F-73D7-43A2-B4C1-B19E189D7DC1Q38723651-78A48B57-1DF3-4F84-A83A-CD8AF6E9F93AQ38785926-7B028794-0FEB-4273-9EE6-2DF5EAF0AB7CQ38810324-03356A63-6271-4867-8395-0103E9A14C20Q39427280-5C1D500E-1793-4BD7-AF33-03F11C2097F7Q40070196-F13312E3-C86D-4FB7-8534-BE8F82C5A193Q40765871-D0BBC887-A292-44C1-B5DB-3EB2B39F7446Q40806221-1E8B7AFB-29B8-44F5-A12E-5ACA6390EEF6
P50
description
researcher ORCID ID = 0000-0002-5264-9229
@en
wetenschapper
@nl
name
Trevor A Mori
@ast
Trevor A Mori
@en
Trevor A Mori
@nl
type
label
Trevor A Mori
@ast
Trevor A Mori
@en
Trevor A Mori
@nl
altLabel
Trevor Mori
@en
prefLabel
Trevor A Mori
@ast
Trevor A Mori
@en
Trevor A Mori
@nl
P106
P31
P496
0000-0002-5264-9229